Intraoperative Dobutamine Plus Norepinephrine to Prevent Postoperative Acute Kidney Injury in Septic Shock
Chinese Perioperative Septic Shock Investigators for the Chinese Peri-Operative Organ Protection Group, Caixia Li, Huiling Li, Honggang Zhang, Xiongxin Zhang, Bing Zhao, 朱少俊, Lixia Huang, 马震俊, Yan Wang, Dongdong Wang, Rui Zhou, Xiawei Hu, Tingting Wen, Guodong Chen, Qinghua Chen, Yu Zhang, Yijie Wu, 宋芳, Ya Wang, Subi Tailaiti, Yuqian Li, Xueying Chen, Qianqian Zhu, Yin Li, Maripat Eliakbar, Xuexue Zhang, Xuan Zhao, Li Wu, Yuqiao Guo, Yankai Ma, Hurxida Nizamidin, Sayira Zak, Ramila Shohrat, 曹婉莹, Zhilong Huang, Rapkat Umarjan, Luowen Lin, Jiawei Liao, 郝建东, Dong Han, Nazakat Sadirdin, Xiangfu Li, Karakat Karken, Hao Cheng, Jinglin Yang, Chunchun Zhai, Wei Wang, Jingyuan Tian, Guihua Zhao and 10 more
Peer-reviewed journalReal-world use
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
CONCLUSIONS AND RELEVANCE Among adult patients with septic shock undergoing surgical source control, intraoperative dobutamine combined with norepinephrine reduced the incidence of new-onset or worsening AKI within 7 postoperative days compared with norepinephrine.
We report VG-3927, an oral, CNS-penetrant small-molecule TREM2 agonist that engages the transmembrane domains of TREM2 and its adaptor DAP12 to promote higher-order receptor complex formation and downstream signaling.
Borislav Dejanovic, Matthew D. Figley, Elizabeth F. Weisman and 19 more — Science Translational Medicine
Peer-reviewed journalClaims a big stepReal-world use
Here we present a machine-learning system that predicts clinical trial success across phases I-IV, independently modeling studies with efficacy versus safety/toxicity primary endpoints.
Furthermore, NZEP TA-Ce treatment reverses gut microbiota dysbiosis and optimizes the composition of microbial metabolites, thereby alleviating anxiety and depressive symptoms associated with IBD.
Fan Zhang, Lei Chen, Shengfu Wang and 9 more — Nature Communications
Peer-reviewed journalBold claims, read criticallyReal-world use
ConclusionsAmong critically ill patients with acute kidney injury who had indications for renal-replacement therapy, intermittent hemodialysis as the initial treatment approach was not shown to be noninferior to continuous renal-replacement therapy with respect to major adverse kidney events by day 90 and was associated with higher mortality.
Stèphane Gaudry, Marouane Boubaya, Guillaume Louis and 42 more — New England Journal of Medicine